228 related articles for article (PubMed ID: 18388150)
21. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection.
Zhang QG; Han D; Wang RM; Dong Y; Yang F; Vadlamudi RK; Brann DW
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):E617-24. PubMed ID: 21808025
[TBL] [Abstract][Full Text] [Related]
22. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation.
Wang Y; Zong H; Chi Y; Hong Y; Yang Y; Zou W; Yun X; Gu J
J Biochem; 2009 Mar; 145(3):331-43. PubMed ID: 19122208
[TBL] [Abstract][Full Text] [Related]
23. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
Long X; Fan M; Bigsby RM; Nephew KP
Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
[TBL] [Abstract][Full Text] [Related]
24. Lysosomal function is involved in 17β-estradiol-induced estrogen receptor α degradation and cell proliferation.
Totta P; Pesiri V; Marino M; Acconcia F
PLoS One; 2014; 9(4):e94880. PubMed ID: 24736371
[TBL] [Abstract][Full Text] [Related]
25. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
Calligé M; Kieffer I; Richard-Foy H
Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
[TBL] [Abstract][Full Text] [Related]
26. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha.
Ong DB; Colley SM; Norman MR; Kitazawa S; Tobias JH
J Bone Miner Res; 2004 Mar; 19(3):447-54. PubMed ID: 15040833
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
30. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Lipfert L; Fisher JE; Wei N; Scafonas A; Su Q; Yudkovitz J; Chen F; Warrier S; Birzin ET; Kim S; Chen HY; Tan Q; Schmidt A; Dininno F; Rohrer SP; Hammond ML; Rodan GA; Freedman LP; Reszka AA
Mol Endocrinol; 2006 Mar; 20(3):516-33. PubMed ID: 16223974
[TBL] [Abstract][Full Text] [Related]
31. Janus kinase 2--a novel negative regulator of estrogen receptor α function.
Gupta N; Grebhardt S; Mayer D
Cell Signal; 2012 Jan; 24(1):151-61. PubMed ID: 21907792
[TBL] [Abstract][Full Text] [Related]
32. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer.
Kameda C; Nakamura M; Tanaka H; Yamasaki A; Kubo M; Tanaka M; Onishi H; Katano M
Br J Cancer; 2010 Feb; 102(4):738-47. PubMed ID: 20087349
[TBL] [Abstract][Full Text] [Related]
33. The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor.
Casa AJ; Hochbaum D; Sreekumar S; Oesterreich S; Lee AV
Mol Cell Endocrinol; 2015 Nov; 415():76-86. PubMed ID: 26272024
[TBL] [Abstract][Full Text] [Related]
34. Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alpha.
Zwart W; Griekspoor A; Rondaij M; Verwoerd D; Neefjes J; Michalides R
Mol Cancer Ther; 2007 May; 6(5):1526-33. PubMed ID: 17513601
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
[TBL] [Abstract][Full Text] [Related]
36. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
37. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
[TBL] [Abstract][Full Text] [Related]
38. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.
Kansra S; Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N
PLoS One; 2010 Apr; 5(4):e10060. PubMed ID: 20419096
[TBL] [Abstract][Full Text] [Related]
39. Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI.
Mao C; Livezey M; Kim JE; Shapiro DJ
Sci Rep; 2016 Oct; 6():34753. PubMed ID: 27713477
[TBL] [Abstract][Full Text] [Related]
40. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
